Tesamorelin

You can buy tesamorelin from Peptide Lab as a laboratory-verified research peptide with 99.4% purity, for research purposes only. Tesamorelin is a stable analogue of growth hormone-releasing hormone (GHRH) that is being studied in research in relation to the release of growth hormone and visceral (abdominal) fat. It is supplied as a lyophilised powder, 10 mg per vial.

Who is Tesamorelin intended for?

Tesamorelin is intended for researchers and laboratories studying the GHRH pathway and its metabolism. Related growth hormone research compounds include CJC-1295 with DAC, Ipamorelin and IGF-1 LR3; see also the Muscle Growth & Growth Hormone category.

Why Peptide Lab?

• Verified purity of 99.4% by HPLC and mass spectrometry.
• Batch documentation is available.
• Lyophilised powder, 10 mg per vial.
• Fast, discreet EU delivery.

Tesamorelin is not a medicinal product and is not intended for human or animal consumption.

Specifications at a glance

• Form: freeze-dried powder
• Packaging: 10 mg per vial
• Purity: 99.4%
• Molecular weight: See CoA
• Laboratory certificate: available on request
• For laboratory and research purposes only

Tesamorelin is based on the full sequence of GHRH, with a chemical modification at the end that protects the molecule from rapid breakdown. This makes it more stable than the natural hormone.

Mechanism of action under investigation

GHRH is the signal that triggers the pituitary gland to release growth hormone. Research is currently being conducted into Tesamorelin in relation to this pathway and, notably, to the reduction of visceral fat — the fat surrounding the organs. This combination makes it a widely studied molecule within endocrine and metabolic research.

This description relates to the mechanism of action as studied in research and does not constitute evidence of efficacy in humans.

The chemical modification that makes Tesamorelin more stable is precisely what sets it apart from short-lived GHRH variants. For researchers, this means a molecule that remains intact for longer in an experimental setting, which facilitates the study of the GHRH pathway. This stability is one of the reasons why Tesamorelin is used so extensively in endocrine research.

Tesamorelin has been extensively studied as a stable GHRH analogue, with the focus often on visceral fat and the regulation of growth hormone.

• Research focus: activation of the GHRH pathway.
• Research focus: visceral fat and metabolic parameters.
• Research focus: stability relative to natural GHRH.

Status and context

Tesamorelin has been approved by the US FDA as a medicinal product (under the brand name Egrifta) for one specific medical indication: HIV-associated lipodystrophy, for which it reduces excess visceral fat. This approval applies exclusively to that indication. The Tesamorelin offered here is a research compound, intended solely for laboratory and research purposes. In the context of sport, GHRH analogues are on the WADA Prohibited List.

The clinical approval of Egrifta illustrates how thoroughly Tesamorelin has been studied, but that approval relates solely to a single medical indication. It is important for researchers to carefully distinguish between the approved medicinal product and this investigational compound, and to use pure, documented materials. Pure starting materials, documented on a batch-by-batch basis, remain the foundation for reliable work.

Tesamorelin is supplied as a lyophilised powder and reconstituted in the laboratory using bacteriostatic water. The steps below describe only the laboratory procedures for research purposes.

1. 1Allow the vial and the bacteriostatic water to reach room temperature.
2. 2Wipe the rubber stoppers of both vials with an alcohol wipe.
3. 3Allow the bacteriostatic water to run slowly down the side of the vial; do not direct it straight onto the powder.
4. 4Gently swirl the vial until everything has dissolved; do not shake.
5. 5Store the solution in the fridge and label it with the date and batch number.

This is a laboratory instruction and not a dosage recommendation for consumption.

Combining approaches in research

Tesamorelin is supplied as a lyophilised powder and reconstituted in the lab using bacteriostatic water. Supplies such as bacteriostatic water, insulin syringes and alcohol wipes can be found under ‘Lab & Accessories’. In growth hormone research, it is sometimes studied alongside CJC-1295 with DAC or Ipamorelin. Document each compound separately, specifying its own purity and batch number, so that observations remain traceable.

Carry out the work in a standardised manner and document the method, concentration and batch number for each experiment. Prepare only the amount you need in the short term and store the rest in the fridge immediately.

Store Tesamorelin in lyophilised (powder) form in a cool, dark place to ensure maximum stability.

Practical storage tips

• Powder form: freezer (-20 °C) for long-term storage; fridge (2–8 °C) for short-term storage.
• After reconstitution: store refrigerated (2–8 °C) and use within a few weeks.
• Avoid direct light, heat and repeated temperature changes.
• Write the reconstitution date and batch number on the vial.

Consistent, cold and dark storage ensures reliable, reproducible measurement results across experiments.

Check the solution for clarity before use. Stable, cold storage ensures reliable comparisons between experiments.